Search

In this work, Green and sustainable sorption method for Li(I) from nitrate medium using a solid functionalised Na+ form of Dowex 50WX8 resin was developed. Scanning electron microscope (SEM), Fourier transform infrared (FT-IR), and energy-dispersive X-ray (EDX) techniques were used for characterisations of Dowex resin before and after the loading of Li ions. The batch technique describes the effects of the different parameters affecting the sorption process was carried out. The batch experiments were studied using 100 mg/L Li(I) at the selected sorption conditions (shaking time = 30 min, adsorbent weight = 0.125 g, temperature= 25°C, and pH = 1) which give sorption efficiency = 60%. The experimental maximum sorption capacity of Dowex 50WX8-Na+ after one sorption cycle was found to be 15 mg/g. Thermodynamic studies indicated that the sorption of the Li(I) on Dowex 50WX8-Na+ resin is physical and exothermic adsorption with spontaneous nature. The maximum desorption efficiency of 85% and 70% was achieved with 1.0 M phosphoric acid and oxalic acid, respectively. An industrial application for green recycling and recovery of Li(I) from spent Li-ion batteries (LIBs) through its leaching with ascorbic acid (1.25 M) and H2O2 (10%) was performed. Lithium ions were selectively recovered (uptake %= 96%) from the spent Li-ions batteries leachate which contains associated metal ions (Co, Ni, and Mn) with Dowex 50Wx8-Na+ sorbent. A flow sheet that presents the performance of industrial method developed for the recycling and separation of Li(I) from (LIBs) under optimum sorption conditions is also provided. [ABSTRACT FROM AUTHOR]

Intramedullary spinal cord metastasis (IMSC) from solid tumors is rare. In this report, we describe the case of a patient treated at our center for breast cancer with intramedullary spinal cord metastases without bone and brain metastases or meningitis. Management of the disease remains challenging even with recent advances in the treatment of metastatic breast cancer. Treatment options include surgery, radiotherapy and chemotherapy. The prognosis of these patients still very poor., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.)

Background: The PI3K protein is involved in the PI3K/AKT/mTOR pathway. Deregulation of this pathway through PIK3CA mutation is common in various tumors. The aim of this work is to identify hotspot mutation at exons 9 and 20 in Tunisian patients with sporadic or hereditary breast cancer., Methods: Hotspot mutations in exon 9 and exon 20 of the PIK3CA gene were identified by QPCR-High Resolution Melting followed by COLD-PCR and sequencing in 63 (42 sporadic cases and 21 hereditary cases) tumor tissues collected from Tunisian patient with breast cancer. MCF7, and BT20 breast cancer cell lines harboring the PIK3CA hotspot mutations E545K and H1047R in exon 9 and exon 20 respectively, were used as controls in HRM experiments., Results: PIK3CA hotspot mutations were detected in 66.7% (28 out of 42) of sporadic BC cases, and in 14.3% (3 out of 21) of hereditary BC. The E545K and the H1048Y were the most prevalent mutations identified in patients with sporadic and hereditary BC, whereas the H1047R hotspot mutation was not found in our patients. Statistical analysis showed that PIK3CA mutation associated with an aggressive behavior in patients with sporadic BC, while it's correlated with age, tumor stage and tumor size in the group patients with hereditary breast cancer., Conclusions: Our results showed a novel PIK3CA hotspot mutation in Tunisian breast cancer patients detected by HRM-COLD-PCR. Moreover, the absence of PIK3CA hotspot mutation associated with good prognosis.